Rutherfordium

From WikiMD's Wellness Encyclopedia

(Redirected from Element 104)

Ernest Rutherford2
Igor Kurchatov 001
Error creating thumbnail:
RfCl4

Rutherfordium is a chemical element with the symbol Rf and atomic number 104. It is named after the New Zealand physicist Ernest Rutherford, who is known as the "father of nuclear physics." Rutherfordium is a synthetic element, and thus it is not found in nature but has to be created in a laboratory through a process called nuclear reaction.

Properties[edit | edit source]

Rutherfordium is a member of the transactinide elements and the period 7 elements in the periodic table, and it belongs to the group of elements known as the transition metals. As with other transactinide elements, rutherfordium's properties are not fully understood due to the element's radioactivity and the limited amount of production. However, it is predicted to be a solid under normal conditions and to have properties similar to its lighter homologs in group 4, such as hafnium and zirconium. This includes a high melting point and a dense metallic form.

Discovery[edit | edit source]

Rutherfordium was first reported in 1964 by a team of scientists at the Joint Institute for Nuclear Research in Dubna, Soviet Union, and almost simultaneously by a team at the Lawrence Berkeley National Laboratory in California, USA. The discovery was the subject of controversy for many years because both teams claimed to have first synthesized the element. The International Union of Pure and Applied Chemistry (IUPAC) eventually credited both teams with the discovery.

Synthesis[edit | edit source]

Rutherfordium is produced by bombarding lighter elements with ions. The most common method involves the collision of californium (Cf) with carbon (C) ions. This process yields rutherfordium isotopes, which are highly radioactive and have short half-lives, making the study of rutherfordium challenging.

Isotopes[edit | edit source]

Several isotopes of rutherfordium have been identified, with mass numbers ranging from 253 to 263. The most stable isotope, rutherfordium-267, has a half-life of about 1.3 hours, while the less stable isotopes have half-lives that are only a few seconds or less.

Applications[edit | edit source]

Due to its radioactivity and the difficulty in producing rutherfordium, it has no significant commercial applications. Its use is primarily for scientific research, particularly in the study of the properties of transactinide elements and the exploration of the periodic table's limits.

See also[edit | edit source]



Stub icon

This chemical element related article is a stub. You can help WikiMD by expanding it.

WikiMD
Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD

Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD

WikiMD's Wellness Encyclopedia

Let Food Be Thy Medicine
Medicine Thy Food - Hippocrates

Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.

Contributors: Prab R. Tumpati, MD